Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride may cause mental and sexual side effects, with hand preference and sexual orientation possibly affecting severity.

Finasteride may cause lasting sexual, mental, and physical symptoms; use with caution.

Finasteride can cause sexual dysfunction and depression, which may persist and require hormonal treatment.

5α-Reductase inhibitors can negatively impact sexual function.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Spironolactone may cause sexual pain and arousal issues in women, which can improve after stopping the drug and using hormone cream.

Using 5α-reductase inhibitors for hair loss can cause lasting sexual, physical, mental, and vascular health issues in men, even after stopping the medication.

Finasteride caused long-term sexual and non-sexual side effects in young men with hair loss.

Post-finasteride syndrome causes sexual, physical, and psychological symptoms, but more research is needed to understand its causes and connection to finasteride.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Early intervention and patient education are crucial for managing alopecia areata.

Men may experience long-term sexual dysfunction after stopping Finasteride.

Stem cell treatment improved life quality and sexual function in women with hair loss.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Finasteride may cause vitiligo, sexual issues, and depression; better treatments and predicting side effects needed.

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

Androgenetic alopecia in men aged 46 is not significantly linked to depression, anxiety, quality of life, self-esteem, or sexual symptoms.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Antidepressants can cause long-term side effects like severe withdrawal symptoms and sexual dysfunction, which can last for months or years after stopping the medication.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The Edwardian medical campaign linked maternal drinking to infant mortality and national decline, influencing hygiene education and leading to a ban on children under 14 from pubs.

The research found that certain characteristics like age, sex, race, marital status, and education level can influence whether alopecia patients stick to their hair loss treatment with topical minoxidil.